HSP90B1 and neoplasm: With the use of GRP94-selective inhibitor PU-WS13, Patel and colleagues demonstrated that GRP94 plays an important role in plasma membrane HER2 stability, and inactivation of GRP94 resulted in reduction of HER2-overexpressing tumor cell viability (166).